The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prilliman, K. R.
Right arrow Articles by Schoenberger, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prilliman, K. R.
Right arrow Articles by Schoenberger, S. P.
The Journal of Immunology, 2002, 169: 4094-4097.
Copyright © 2002 by The American Association of Immunologists


Cutting Edge

Cutting Edge: A Crucial Role for B7-CD28 in Transmitting T Help from APC to CTL1

Kiley R. Prilliman*, Edward E. Lemmens*, Georgia Palioungas*, Thomas G. Wolfe*, James P. Allison{dagger}, Arlene H. Sharpe{ddagger} and Stephen P. Schoenberger2,*

* Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121; {dagger} Howard Hughes Research Institute, Division of Immunology, Department of Molecular and Cellular Biology, University of California, Berkeley, CA 94720; {ddagger} Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115

Although APC activation via CD40-CD40L signaling plays a critical role in enabling CD4+ T cells to provide the "help" necessary for cross-priming of naive CTL, it is unclear how this makes the APC competent for priming. We have investigated the roles of B7-1/B7-2 and their TCRs CD28/CTLA-4 in cross-priming of CD4-dependent CTL in vivo. We find that both CD28 and B7-1/B7-2 are required for CD40-activated APC to cross-prime CTL, and that priming by CD40-activated APC was prevented by blockade of CD28. Conversely, augmenting CD28 signals with an agonistic Ab bypassed the requirement for CD4+ T help or CD40 activation. Interestingly, blockade of the negative regulatory B7 receptor CTLA-4 failed to prime CTL in the absence of T help. These results support a model in which activation-induced up-regulation of B7 molecules on APC leads to increased CD28 signaling and a commitment to cross-priming of CD4-dependent CTL.




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. E. Hamilton-Williams, X. Martinez, J. Clark, S. Howlett, K. M. Hunter, D. B. Rainbow, L. Wen, M. J. Shlomchik, J. D. Katz, G. F. Beilhack, et al.
Expression of Diabetes-Associated Genes by Dendritic Cells and CD4 T Cells Drives the Loss of Tolerance in Nonobese Diabetic Mice
J. Immunol., August 1, 2009; 183(3): 1533 - 1541.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. L. VanOosten and T. S. Griffith
Activation of Tumor-Specific CD8+ T Cells after Intratumoral Ad5-TRAIL/CpG Oligodeoxynucleotide Combination Therapy
Cancer Res., December 15, 2007; 67(24): 11980 - 11990.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. B. Borowski, A. C. Boesteanu, Y. M. Mueller, C. Carafides, D. J. Topham, J. D. Altman, S. R. Jennings, and P. D. Katsikis
Memory CD8+ T Cells Require CD28 Costimulation
J. Immunol., November 15, 2007; 179(10): 6494 - 6503.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Otahal, B. B. Knowles, S. S. Tevethia, and T. D. Schell
Anti-CD40 Conditioning Enhances the TCD8 Response to a Highly Tolerogenic Epitope and Subsequent Immunotherapy of Simian Virus 40 T Antigen-Induced Pancreatic Tumors
J. Immunol., November 15, 2007; 179(10): 6686 - 6695.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. E. Matthews, J. S. Qin, J. Yang, I. F. Hermans, M. J. Palmowski, V. Cerundolo, and F. Ronchese
Increasing the Survival of Dendritic Cells In Vivo Does Not Replace the Requirement for CD4+ T Cell Help during Primary CD8+ T Cell Responses
J. Immunol., November 1, 2007; 179(9): 5738 - 5747.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Y. Taraban, T. F. Rowley, D. F. Tough, and A. Al-Shamkhani
Requirement for CD70 in CD4+ Th Cell-Dependent and Innate Receptor-Mediated CD8+ T Cell Priming.
J. Immunol., September 1, 2006; 177(5): 2969 - 2975.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Wuthrich, T. Warner, and B. S. Klein
CD28 Is Required for Optimal Induction, but Not Maintenance, of Vaccine-Induced Immunity to Blastomyces dermatitidis
Infect. Immun., November 1, 2005; 73(11): 7436 - 7441.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Lim, K. Gee, S. Mishra, and A. Kumar
Regulation of B7.1 Costimulatory Molecule Is Mediated by the IFN Regulatory Factor-7 through the Activation of JNK in Lipopolysaccharide-Stimulated Human Monocytic Cells
J. Immunol., November 1, 2005; 175(9): 5690 - 5700.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. P.F. Gade, W. Hassen, E. Santos, G. Gunset, A. Saudemont, M. C. Gong, R. Brentjens, X.-S. Zhong, M. Stephan, J. Stefanski, et al.
Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
Cancer Res., October 1, 2005; 65(19): 9080 - 9088.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. N. J. Bullock and H. Yagita
Induction of CD70 on Dendritic Cells through CD40 or TLR Stimulation Contributes to the Development of CD8+ T Cell Responses in the Absence of CD4+ T Cells
J. Immunol., January 15, 2005; 174(2): 710 - 717.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Lustgarten, A. L. Dominguez, and M. Thoman
Aged Mice Develop Protective Antitumor Immune Responses with Appropriate Costimulation
J. Immunol., October 1, 2004; 173(7): 4510 - 4515.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Chen, P. S. Heeger, and A. Valujskikh
In Vivo Helper Functions of Alloreactive Memory CD4+ T Cells Remain Intact Despite Donor-Specific Transfusion and Anti-CD40 Ligand Therapy
J. Immunol., May 1, 2004; 172(9): 5456 - 5466.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.